Search Results

Alzheimer's disease: Seeing the signs early

Author: Leifer, Bennett P.

Source: Journal of the American Academy of Nurse Practitioners, Volume 21, Number 11, November 2009 , pp. 588-595(8)

Publisher: Blackwell Publishing

Rivastigmine for cognitive impairment after spontaneous subarachnoid haemorrhage: a pilot study

Authors: Wong, G. K.-C.; Wong, R.; Mok, V.; Wong, A.; Fan, D.; Leung, G.; Chan, A.; Poon, W. S.

Source: Journal of Clinical Pharmacy & Therapeutics, Volume 34, Number 6, December 2009 , pp. 657-663(7)

Publisher: Blackwell Publishing

Mediators of tau phosphorylation in the pathogenesis of Alzheimer's disease

Authors: Hanger, Diane P; Seereeram, Anjan; Noble, Wendy

Source: Expert Review of Neurotherapeutics, Volume 9, Number 11, November 2009 , pp. 1647-1666(20)

Publisher: Expert Reviews

First analysis of pharma uptake after NICE approval

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 587, 2009-09-19 , pp. 5-5(1)

Publisher: Adis International

Safety/Tolerability and Efficacy of Rivastigmine in Taiwanese Patients with Alzheimer's Disease: A Prospective Post-Marketing Surveillance Study

Authors: Chiu, Pai-Yi; Dai, Dao-En; Hsu, Hai-Pei; Lee, Chao; Lin, Juei-Jueng; Kuo, Hung-Chou; Huang, Ying-Chih; Liu, Yung-Chang; Tsai, Ching-Piao

Source: Clinical Drug Investigation, Volume 29, Number 11, 1 November 2009 , pp. 729-738(10)

Publisher: Adis International

The use of gastrointestinal intubation studies for controlled release development

Author: Sutton, Steven C.

Source: British Journal of Clinical Pharmacology, Volume 68, Number 3, September 2009 , pp. 342-354(13)

Publisher: Blackwell Publishing

Treatment of Mild Cognitive Impairment (MCI)

Author: Farlow, M. R.

Source: Current Alzheimer Research, Volume 6, Number 4, August 2009 , pp. 362-367(6)

Publisher: Bentham Science Publishers

A randomized controlled trial of rivastigmine for chronic sequels of traumatic brain injury—What it showed and taught?

Authors: Tenovuo, Olli; Alin, Jouni; Helenius, Hans

Source: Brain Injury, Volume 23, Number 6, June 2009 , pp. 548-558(11)

Publisher: Informa Healthcare

Rivastigmine in Parkinson's disease dementia

Authors: Chitnis, Shilpa; Rao, Jayaraman

Source: Expert Opinion on Drug Metabolism and Toxicology, Volume 5, Number 8, August 2009 , pp. 941-955(15)

Publisher: Informa Healthcare

Persistence with Cholinesterase Inhibitor Therapy for Dementia: An Observational Administrative Health Database Study

Authors: Herrmann, Nathan; Binder, Carin; Dalziel, William; Smyth, Steve; Camacho, Fernando

Source: Drugs & Aging, Volume 26, Number 5, May 5 2009 , pp. 403-407(5)

Publisher: Adis International

Various drugs: QT interval prolongation, torsade de pointes and heart arrest: 21 case reports

Source: Reactions, Volume 1, Number 1252, 2009-05-16 , pp. 40-40(1)

Publisher: Adis International

Novel Regimens and Delivery Systems in the Pharmacological Treatment of Alzheimer's Disease

Authors: Bassil, Nazem; Grossberg, George T.

Source: CNS Drugs, Volume 23, Number 4, 2009 , pp. 293-307(15)

Publisher: Adis International

Novel Convenient Synthesis of Rivastigmine

Authors: Hu, Meng; Zhang, Fu-Li; Xie, Mei-Hua

Source: Synthetic Communications, Volume 39, Number 9, January 2009 , pp. 1527-1533(7)

Publisher: Taylor and Francis Ltd

Methylthioninium chloride reverses cognitive deficits induced by scopolamine: comparison with rivastigmine

Authors: Deiana, Serena; Harrington, Charles; Wischik, Claude; Riedel, Gernot

Source: Psychopharmacology, Volume 202, Numbers 1-3, January 2009 , pp. 53-65(13)

Publisher: Springer

Various drugs: Cognitive and motor impairment in an elderly patient: case report

Source: Reactions, Volume 1, Number 1246, 2009-04-04 , pp. 34-34(1)

Publisher: Adis International

Pharmacokinetics of a novel transdermal rivastigmine patch for the treatment of Alzheimer's disease: a review

Authors: Kurz, A.; Farlow, M.; Lefèvre, G.

Source: International Journal of Clinical Practice, Volume 63, Number 5, May 2009 , pp. 799-805(7)

Publisher: Blackwell Publishing

Cholinesterase Inhibitors and Beyond

Authors: Pepeu, Giancarlo; Giovannini, Maria G.

Source: Current Alzheimer Research, Volume 6, Number 2, April 2009 , pp. 86-96(11)

Publisher: Bentham Science Publishers

Rivastigmine: Psychiatric symptoms in an elderly patient: case report

Source: Reactions, Volume 1, Number 1242, 2009-03-07 , pp. 41-41(1)

Publisher: Adis International

Long-term effects of rivastigmine capsules in patients with traumatic brain injury

Authors: Silver, Jonathan; Koumaras, Barbara; Meng, Xiangyi; Potkin, Steven; Reyes, Patricio; Harvey, Philip; Katz, Douglas; Gunay, Ibrahim; Arciniegas, David

Source: Brain Injury, Volume 23, Number 2, February 2009 , pp. 123-132(10)

Publisher: Informa Healthcare

Different Cholinesterase Inhibitor Effects on CSF Cholinesterases in Alzheimer Patients

Authors: Nordberg, Agneta; Darreh-Shori, Taher; Peskind, Elaine; Soininen, Hilkka; Mousavi, Malahat; Eagle, Gina; Lane, Roger

Source: Current Alzheimer Research, Volume 6, Number 1, February 2009 , pp. 4-14(11)

Publisher: Bentham Science Publishers